Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
Go back to Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results| (NASDAQ: CRNX) | Delayed: 83.65 -0.07 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.72 | 52 Week High | $ | |||
| Open | $83.78 | 52 Week Low | $ | |||
| Day High | $83.79 | P/E | N/A | |||
| Day Low | $83.64 | EPS | $ | |||
| Volume | 4,268,878 | |||||

